Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Olema Pharmaceuticals (OLMA)
NASDAQ:OLMA
RESEARCH TOOLSreports
Holding OLMA?
Track your performance easily
See the Price Targets and Ratings of:
OLMA Analyst Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
OLMA Stock 12 Month Forecast
Average Price Target
$28.00
▲(120.13% Upside)
| Highest Price Target$30.00 | Average Price Target$28.00 | Lowest Price Target$26.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
LifeSci Capital
Reiterated
10/24/24
Capital One Financial
Assigned
10/24/24
H.C. Wainwright
Reiterated
10/23/24
Goldman Sachs
Reiterated
09/10/24
J.P. Morgan
$33→$31
Buy
143.71%
Upside
Reiterated
08/08/24
Olema Oncology price target lowered to $31 from $33 at JPMorganOlema Oncology price target lowered to $31 from $33 at JPMorgan
TD Cowen
―
Buy
―
Assigned
08/07/24
Buy Rating Affirmed: Promising Clinical Trial Results and Future Prospects for Olema Pharmaceuticals
Oppenheimer
$21→$30
Buy
135.85%
Upside
Reiterated
08/07/24
Oppenheimer Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA)
Jefferies
$30
Buy
135.85%
Upside
Assigned
06/02/24
Jefferies Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA)
Canaccord Genuity
$24
Buy
88.68%
Upside
Reiterated
05/15/24
Buy Rating Affirmed for Olema Pharmaceuticals Amid Promising Clinical Trial Results for Breast Cancer Therapy
Citi
$20
Buy
57.23%
Upside
Reiterated
05/15/24
Buy Rating Affirmed for Olema Pharmaceuticals on Strong Clinical Trial Data for Palazestrant and Ribociclib Combination
Best Analysts Covering Olema Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy OLMA and Sell After:
1 Month
xxx
Success Rate
10/17 ratings generated profit
Average Return
+5.22%
assigned a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 58.82% of your transactions generating a profit, with an average return of +5.22% per trade.
3 Months
xxx
Success Rate
11/17 ratings generated profit
Average Return
+20.17%
reiterated a xxx
rating 21 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 64.71% of your transactions generating a profit, with an average return of +20.17% per trade.
1 Year
Success Rate
12/17 ratings generated profit
Average Return
+92.52%
reiterated a buy rating 21 days ago
Copying Emily Bodnar's trades and holding each position for 1 Year would result in 70.59% of your transactions generating a profit, with an average return of +92.52% per trade.
2 Years
xxx
Success Rate
13/17 ratings generated profit
Average Return
+96.02%
reiterated a xxx
rating 21 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 76.47% of your transactions generating a profit, with an average return of +96.02% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
OLMA Analyst Recommendation Trends
Rating
May 24
Jun 24
Aug 24
Sep 24
Oct 24
Strong Buy
21
18
20
9
9
Buy
2
1
2
1
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
23
19
22
10
10
Each month's total comprises the sum of three months' worth of ratings.
OLMA Financial Forecast
OLMA Stock Forecast FAQ
What is OLMA’s average 12-month price target, according to analysts?
Based on analyst ratings, Olema Pharmaceuticals’s 12-month average price target is $28.00.
What is OLMA’s upside potential, based on the analysts’ average price target?
Olema Pharmaceuticals has 120.13% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is OLMA a Buy, Sell or Hold?
Olema Pharmaceuticals has a consensus rating of Strong Buy which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Olema Pharmaceuticals’s price target?
The average price target for Olema Pharmaceuticals is $28.00. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $30.00 ,the lowest forecast is $26.00. The average price target represents 120.13% Increase from the current price of $12.72.
The highest analyst price target is $30.00 ,the lowest forecast is $26.00. The average price target represents 120.13% Increase from the current price of $12.72.
What do analysts say about Olema Pharmaceuticals?
Olema Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of OLMA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.